I can speak to the policy intent of it. It refers to products that may release. Whereas CEPA has been focused on substances, there is an intention throughout Bill C-30 to allow it to also address products that release substances without necessarily containing them. We are aware of a couple of instances in which that could come into play.
That's the overall intention. I can't speak to the legal aspects of it, but it was to make it possible for the regulation of products that may release, as opposed to products that simply contain.